Associate Marketing Director at Palvella Therapeutics | Wayne, PA

Palvella Therapeutics

Associate Marketing Director

Wayne, PA (On-site)

Salary Not AvailableMid LevelFull time

Posted 4 months ago

Top 1% of applicants do these two things.

The other 99% submit and hope. You're about to do something different.

Job Summary

Lead Palvella’s first commercial launch in a rare disease, coordinating cross‑functional teams to deliver launch‑ready materials and field tools.

Own launch readiness with Medical Affairs, Market Access, Regulatory, and Sales, plus agency partners.
Must-have: Strong launch track record in rare disease and a collaborative, hands‑on style.
Standout: Help build Palvella’s first commercial brand and guide strategy with market insights.

Job Description

Responsibilities

Drive commercial launch readiness, partnering closely with cross‑functional teams across Medical Affairs, Market Access, Field Leadership, Regulatory, and Clinical.
Manage agency partners to deliver creative, digital, and strategic work aligned to brand goals, including high‑impact disease‑education and product-specific content. This may include congress materials, digital assets, and field team tools for HCPs, as well as engaging resources and materials for patients/caregivers and other key stakeholders.
Lead promotional materials through internal approval processes, including medical, legal, and regulatory reviews.
Incorporate insights from market research and customer interactions into work, and contribute to the evolution of brand strategy, opportunity assessments, and competitive differentiation.
Oversee project timelines, budgets, and performance tracking across all marketing initiatives.
Represent Palvella in customer interactions and at medical meetings/conferences.
Prepare executive‑level presentations and strategic updates for senior leadership.
Demonstrate high integrity and comply with all laws and company policies.

Requirements

The ideal candidate has experience working in a rare disease where ‘patient finding’ is not simple, and promotional success is accomplished through a combination of innovative digital engagement tactics and in-person sales efforts.
A strong launch track record and a hands-on collaborative style are required.

Palvella Therapeutics

Palvella Therapeutics (NASDAQ: PVLA) is a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapies to treat patients suffering from serious, rare genetic skin diseases for which there are no FDA-approved therapies. The Company is developing a broad pipeline of product candidates based on its patented QTORINTM platform, with an initial focus on serious, rare genetic skin diseases, many of which are lifelong in nature. Its lead product candidate, QTORIN 3.9% rapamycin anhydrous gel (QTORINTM rapamycin), is currently in clinical development for microcystic lymphatic malformations (microcystic LMs) and cutaneous venous malformations. For more information, please go to www.palvellatx.com.

Founded in 2015

Wayne, Pennsylvania, USA

36 employees (1 in marketing)

palvellatx.com